Parkwalk Advisors

Funds United Kingdom university spinouts through Parkwalk investment vehicles that bridge lab research and growth-stage commercialization.

Parkwalk Advisors is a UK equity investor and EIS fund manager that backs university spinouts with capital, support, and tax-advantaged investment vehicles. The firm was established in 2009, joined IP Group plc in 2017, and has built its business around helping research-led companies move from university labs into the market.

Its funds focus on deeptech, healthtech, and cleantech, with particular interest in quantum computing, AI, software, life sciences, hardware, and future mobility. Parkwalk invests from seed through Series C, and its university-linked vehicles cover institutions such as Cambridge, Oxford, Imperial, Bristol, and the northern university consortium that includes Leeds, Liverpool, Manchester, and Sheffield. The funds are equity instruments, not grants.

Parkwalk is most relevant to founders with defensible IP and a spinout structure that can support institutional equity. The firm works through EIS and knowledge-intensive EIS funds, co-invests with other backers, and positions itself as a bridge between academic innovation and commercial scale.